Virtual Reality Self-Hypnosis for Pain Relief

Recruiting in Palo Alto (17 mi)

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Icahn School of Medicine at Mount Sinai

No Placebo Group

Trial Summary

What is the purpose of this trial?This single-site study of self-hypnosis software using an off-the-shelf virtual reality (VR) device (OculusGo™) to determine the software's safety, usability, and preliminary efficacy in pain relief for HIV-associated chronic pain patients. This is funded under the i Prism Funding through Mount Sinai Innovations.

Eligibility Criteria

This trial is for individuals with chronic pain related to HIV, including musculoskeletal and neuropathic pain. Participants should be comfortable using a VR headset as part of the treatment process.

Inclusion Criteria

Fluent in English

I have been on HIV medication for at least 90 days without changes.

My average pain level is 3 or higher on a scale of 0-10.

+5 more

Exclusion Criteria

A psychiatric disorder, medical condition, or other life circumstance, which in the opinion of the PI, would contraindicate attendance at sessions, or make it unlikely that the participant could successfully complete the study procedures

I have an injury to my eyes, face, or neck that prevents me from using VR devices.

Currently pregnant or planning to become pregnant during the study period

+6 more

Participant Groups

The study tests a self-hypnosis software delivered through an OculusGo™ VR device, aiming to assess its safety, ease of use, and initial effectiveness in managing HIV-associated chronic pain.

1Treatment groups

Experimental Treatment

Group I: HIV-associated Chronic Pain PatientsExperimental Treatment1 Intervention

The participants will be enrolled into an open label arm to determine feasibility and useability of the combination device.